Standout Papers
- The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users (1995)
- Extent of illicit drug use and dependence, and their contribution to the global burden of disease (2012)
- Adverse health effects of non-medical cannabis use (2009)
- Prevalence, comorbidity, disability and service utilisation (2001)
- Cannabis use and mental health in young people: cohort study (2002)
- Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy (1992)
- Global statistics on alcohol, tobacco and illicit drug use: 2017 status report (2018)
- Development of a short ‘readiness to change’ questionnaire for use in brief, opportunistic interventions among excessive drinkers (1992)
- Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010 (2013)
- Adverse effects of cannabis (1998)
- Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. (1989)
- What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? (2014)
- The increasing global health priority of substance use in young people (2016)
- Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations (2017)
- Prevention, early intervention, harm reduction, and treatment of substance use in young people (2016)
- Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis (2019)
- Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies (2018)
- Cannabis use and cannabis use disorder (2021)
- Public health implications of legalising the production and sale of cannabis for medicinal and recreational use (2019)
- New psychoactive substances: challenges for drug surveillance, control, and public health responses (2019)
- Assessing the public health impacts of legalizing recreational cannabis use: the US experience (2020)
- What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis (2020)
- Tobacco and nicotine use (2022)
Immediate Impact
4 by Nobel laureates 4 from Science/Nature 101 standout
Citing Papers
Pharmacotherapy for Alcohol Use Disorder
2023 Standout
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Works of Wayne Hall being referenced
Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study
2008
Naltrexone in the treatment of male alcoholics - an effectiveness study in Singapore
2001
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Wayne Hall | 17004 | 13943 | 9269 | 1.0k | 45.1k | |
| Louisa Degenhardt | 21385 | 9395 | 13502 | 666 | 45.6k | |
| Deborah S. Hasin | 19053 | 9912 | 6263 | 570 | 48.9k | |
| Jürgen Rehm | 25307 | 5417 | 8879 | 1.0k | 54.2k | |
| Bridget F. Grant | 21617 | 6191 | 5290 | 355 | 52.4k | |
| Michael Farrell | 8265 | 2918 | 5878 | 731 | 27.6k | |
| Hans‐Ulrich Wïttchen | 6186 | 5745 | 7967 | 789 | 65.4k | |
| Theo Vos | 5991 | 8079 | 6938 | 297 | 48.4k | |
| Sandro Galea | 7922 | 2843 | 7420 | 1.1k | 57.3k | |
| Katherine M. Keyes | 6873 | 3686 | 4980 | 477 | 24.2k | |
| David M. Fergusson | 6630 | 3912 | 4877 | 467 | 43.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...